Lifespan of glucose-controlling molecule could be extended, helping protect against obesity, research suggests by Dave Rogers, Nottingham Trent University Editors' notes ...

Molecular Templates Inc. company and executive profile by Barron's. View the latest MTEMQ company infomation and executive bios.

Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases.

DiaMonTech Out of Germany, DiaMonTech has developed a system that uses molecular spectroscopy — the science of absorption of light by molecules — to detect glucose molecules through the skin.

(RTTNews) - Shares of Molecular Templates, Inc. (MTEM) plunged by 54.98% following a notification from the Nasdaq that the company has failed to meet essential listing requirements.

Molecular Templates disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act’s Safe Harbor for forward-looking statements.

PURPOSEPD-1 inhibition is effective in patients with mismatch repair deficient (dMMR) solid tumors in a tumor-agnostic fashion. However, dMMR testing by immunohistochemistry (IHC) is not routinely ...

And as part of the ISC24 festivities this week, Cerebras and researchers from Tri-Labs have publishing a paper on how a molecular dynamics application that relevant to the management of the nuclear ...

High-precision blood glucose level prediction achieved by few-molecule reservoir computing Advancement in compact AI device development employing molecular vibrations and operation verification ...